CoChat

Plasma p‐tau231, p‐tau181, PET Biomarkers, and Cognitive Change in Older Adults

Meyer, Pierre‐François, Ashton, Nicholas J., Karikari, Thomas K., Strikwerda‐Brown, Cherie, Köbe, Theresa, Gonneaud, Julie, Pichet Binette, Alexa, Ozlen, Hazal, Yakoub, Yara, Simrén, Joel, Pannee, Josef, Lantero‐Rodriguez, Juan, Labonté, Anne, Baker, Suzanne L., Schöll, Michael, Vanmechelen, Eugeen, Breitner, John C. S., Zetterberg, Henrik, Blennow, Kaj, Poirier, Judes, Villeneuve, Sylvia, Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease (PREVENT‐AD) Research Group · 2022 · Annals of Neurology
Cited by 91

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Objective: The objective of this study was to evaluate novel plasma p‐tau231 and p‐tau181, as well as Aβ 40 and Aβ 42 assays as indicators of tau and Aβ pathologies measured with positron emission tomography (PET), and their association with cognitive change, in cognitively unimpaired older adults. Methods: In a cohort of 244 older adults at risk of Alzheimer's disease (AD) owing to a family history of AD dementia, we measured single molecule array (Simoa)‐based plasma tau biomarkers (p‐tau231 and p‐tau181), Aβ 40 and Aβ 42 with immunoprecipitation mass spectrometry, and Simoa neurofilament light (NfL). A subset of 129 participants underwent amyloid‐β (18 F‐NAV4694) and tau (18 F‐flortaucipir) PET assessments. We investigated plasma biomarker associations with Aβ and tau PET at the global and voxel level and tested plasma biomarker combinations for improved detection of Aβ‐PET positivity. We also investigated associations with 8‐year cognitive change. Results: Plasma p‐tau biomarkers correlated with flortaucipir binding in medial temporal, parietal, and inferior temporal regions. P‐tau231 showed further associations in lateral parietal and occipital cortices. Plasma Aβ 42/40 explained more variance in global Aβ‐PET binding than Aβ 42 alone. P‐tau231 also showed strong and widespread associations with cortical Aβ‐PET binding. Combining Aβ 42/40 with p‐tau231 or p‐tau181 allowed for good distinction between Aβ‐negative and ‐positive participants (area under the receiver operating characteristic curve [AUC] range = 0.81–0.86). Individuals with low plasma Aβ 42/40 and high p‐tau experienced faster cognitive decline. Interpretation: Plasma p‐tau231 showed more robust associations with PET biomarkers than p‐tau181 in presymptomatic individuals. The combination of p‐tau and Aβ 42/40 biomarkers detected early AD pathology and cognitive decline. Such markers could be used as prescreening tools to reduce the cost of prevention trials. ANN NEUROL 2022;91:548–560

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.26308

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 91

Metadata

Authors
Meyer, P., Ashton, N. J., Karikari, T. K., Strikwerda‐Brown, C., Köbe, T., Gonneaud, J., Pichet Binette, A., Ozlen, H., Yakoub, Y., Simrén, J., Pannee, J., Lantero‐Rodriguez, J., Labonté, A., Baker, S. L., Schöll, M., Vanmechelen, E., Breitner, J. C. S., Zetterberg, H., Blennow, K., Poirier, J., Villeneuve, S., & Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease (PREVENT‐AD) Research Group
Venue
Annals of Neurology
Publisher
Wiley
Published
2022-02-18
Volume
91
Issue
4
Pages
548-560
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W4210249852
Cited by
91
References
29
FWCI
12.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma p‐tau231, p‐tau181, PET Biomarkers, and Cognitive Change in Older Adults. https://app.cochat.ai/papers/10.1002/ana.26308
The paper
Meyer, P., Ashton, N. J., Karikari, T. K., Strikwerda‐Brown, C., Köbe, T., Gonneaud, J., Pichet Binette, A., Ozlen, H., Yakoub, Y., Simrén, J., Pannee, J., Lantero‐Rodriguez, J., Labonté, A., Baker, S. L., Schöll, M., Vanmechelen, E., Breitner, J. C. S., Zetterberg, H., Blennow, K., . . . Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease (PREVENT‐AD) Research Group. (2022). Plasma p‐tau231, p‐tau181, PET Biomarkers, and Cognitive Change in Older Adults. Annals of Neurology. https://doi.org/10.1002/ana.26308

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.